Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 241

1.

A study of the antimicrobial activity of selected synthetic and naturally occurring quinolines.

O'Donnell F, Smyth TJ, Ramachandran VN, Smyth WF.

Int J Antimicrob Agents. 2010 Jan;35(1):30-8. doi: 10.1016/j.ijantimicag.2009.06.031. Epub 2009 Sep 11.

PMID:
19748233
2.

A study of the antimicrobial activity of selected naturally occurring and synthetic coumarins.

Smyth T, Ramachandran VN, Smyth WF.

Int J Antimicrob Agents. 2009 May;33(5):421-6. doi: 10.1016/j.ijantimicag.2008.10.022. Epub 2009 Jan 19.

PMID:
19155158
4.

In vitro activity of moxifloxacin against common clinical bacterial isolates in Taiwan.

Sheng WH, Wang JT, Chen YC, Chang SC, Luh KT.

J Microbiol Immunol Infect. 2001 Sep;34(3):178-84.

PMID:
11605808
6.

Antimicrobial susceptibility of tigecycline and comparators against bacterial isolates collected as part of the TEST study in Europe (2004-2007).

Nørskov-Lauritsen N, Marchandin H, Dowzicky MJ.

Int J Antimicrob Agents. 2009 Aug;34(2):121-30. doi: 10.1016/j.ijantimicag.2009.02.003. Epub 2009 Apr 1.

PMID:
19342205
7.

Derivatives of aryl-4-guanidinomethylbenzoate and N-aryl-4-guanidinomethylbenzamide as new antibacterial agents: synthesis and bioactivity.

Yu WY, Yang LX, Xie JS, Zhou L, Jiang XY, Zhu DX, Muramatsu M, Wang MW.

Acta Pharmacol Sin. 2008 Feb;29(2):267-77.

PMID:
18215358
8.

In vitro activity of S-(3,4-dichlorobenzyl)isothiourea hydrochloride and novel structurally related compounds against multidrug-resistant bacteria, including Pseudomonas aeruginosa and Burkholderia cepacia complex.

Nicholson A, Perry JD, James AL, Stanforth SP, Carnell S, Wilkinson K, Anjam Khan CM, De Soyza A, Gould FK.

Int J Antimicrob Agents. 2012 Jan;39(1):27-32. doi: 10.1016/j.ijantimicag.2011.08.015. Epub 2011 Oct 10.

PMID:
21993484
9.

Antistaphylococcal activities of CG400549, a new bacterial enoyl-acyl carrier protein reductase (FabI) inhibitor.

Park HS, Yoon YM, Jung SJ, Kim CM, Kim JM, Kwak JH.

J Antimicrob Chemother. 2007 Sep;60(3):568-74. Epub 2007 Jul 2.

11.

New thioureides of 2-(4-methylphenoxymethyl) benzoic acid with antimicrobial activity.

Drăcea O, Larion C, Chifiriuc MC, Raut I, Limban C, Niţulescu GM, Bădiceanu CD, Israil AM.

Roum Arch Microbiol Immunol. 2008 Jul-Dec;67(3-4):92-7.

PMID:
19496477
12.

In vitro activity of para-guanidinoethylcalix[4]arene against susceptible and antibiotic-resistant Gram-negative and Gram-positive bacteria.

Grare M, Mourer M, Fontanay S, Regnouf-de-Vains JB, Finance C, Duval RE.

J Antimicrob Chemother. 2007 Sep;60(3):575-81. Epub 2007 Jul 10.

13.

Synthesis and evaluation of antibacterial activity of 7-alkyloxy-4,5-dihydro-imidazo[1,2-a]quinoline derivatives.

Sun XY, Wu R, Wen X, Guo L, Zhou CP, Li J, Quan ZS, Bao J.

Eur J Med Chem. 2013 Feb;60:451-5. doi: 10.1016/j.ejmech.2012.12.034. Epub 2012 Dec 26.

PMID:
23321259
14.

[Comparative studies on activities of antimicrobial agents against causative organisms isolated from patients with urinary tract infections (1995). I. Susceptibility distribution].

Kumamoto Y, Tsukamoto T, Hirose T, Yokoo A, Hikichi Y, Shigeta S, Takanashi T, Shiraiwa Y, Ogiwara M, Yoshida H, Imafuku Y, Murai M, Watanabe K, Uchida H, Kobayashi Y, Matsuda S, Fujime M, Fujita K, Igari J, Oguri T, Kosakai N, Yamaguchi K, Matsumoto T, Kashitani F, Tanaka M.

Jpn J Antibiot. 1997 Mar;50(3):219-50. Japanese.

PMID:
9575353
15.

Synthesis and antimicrobial activity of novel 2-thiazolylimino-5-arylidene-4-thiazolidinones.

Vicini P, Geronikaki A, Anastasia K, Incerti M, Zani F.

Bioorg Med Chem. 2006 Jun 1;14(11):3859-64. Epub 2006 Feb 20.

PMID:
16488614
16.

Investigation of antibiotic and antibacterial agent cross-resistance in target bacteria from homes of antibacterial product users and nonusers.

Cole EC, Addison RM, Rubino JR, Leese KE, Dulaney PD, Newell MS, Wilkins J, Gaber DJ, Wineinger T, Criger DA.

J Appl Microbiol. 2003;95(4):664-76.

17.

Pyrrolobenzodiazepine dimers: novel sequence-selective, DNA-interactive, cross-linking agents with activity against Gram-positive bacteria.

Hadjivassileva T, Thurston DE, Taylor PW.

J Antimicrob Chemother. 2005 Sep;56(3):513-8. Epub 2005 Jul 15.

19.

In vitro antibacterial activity of moxifloxacin against hospital isolates: a multicentre study.

Soussy CJ, Nguyen J, Goldstein F, Dabernat H, Andremont A, Leclercq R, Drugeon H, Cavallo P, Chardon H, Etienne J, Rio Y, Courvalin P.

Clin Microbiol Infect. 2003 Oct;9(10):997-1005.

20.

Antimicrobial activity of tigecycline tested against nosocomial bacterial pathogens from patients hospitalized in the intensive care unit.

Sader HS, Jones RN, Dowzicky MJ, Fritsche TR.

Diagn Microbiol Infect Dis. 2005 Jul;52(3):203-8.

PMID:
16105565
Items per page

Supplemental Content

Write to the Help Desk